A hospital based in Washington, D.C., will no longer provide gender-affirming medications to patients.
Children’s National Hospital announced the change on its website. The change for the “Gender Development Program” will go into effect Aug. 30.
“In light of escalating legal and regulatory risks to Children’s National, our providers, and the families we serve, we will be discontinuing the prescription of gender-affirming medications,” the website post said. “Mental health and other support services for LGBT patients remain available. You are always welcome at Children’s National for your other medical needs.”
On July 9, the Department of Justice announced it had sent more than 20 subpoenas to “doctors and clinics involved in performing transgender medical procedures on children,” Fox News reported.
It was not clear if Children’s National received a subpoena.
“Medical professionals and organizations that mutilated children in the service of a warped ideology will be held accountable by this Department of Justice,” Attorney General Pamela Bondi said in a statement at the time.
The hospital welcomes patients to be treated there for other things.
“LGBT patients are always welcome at Children’s National for other medical needs and treatment,” a hospital spokesperson said.
President Donald Trump signed an executive order — “Protecting Children From Chemical and Surgical Mutilation” — in late January.
The measure ordered federal agencies to cut Medicare, Medicaid as well as other federal funding from providers offering so-called “gender‑affirming care” to patients under the age of 19.
IJRIJR
